Disorder . | Intervention number . | Intervention description . | Coverage . |
---|---|---|---|
Depression | DEP1 | Older antidepressants (TCA) | 30% |
DEP2 | Newer antidepressants (SSRI) | 30% | |
DEP3 | Psychotherapy | 30% | |
DEP4 | Older antidepressants (TCA) and psychotherapy | 30% | |
DEP5 | Newer antidepressants (SSRI) and psychotherapy | 30% | |
DEP6 | Maintenance: Older antidepressants (TCA) and psychotherapy | 30% | |
DEP7 | Maintenance: Newer antidepressants (SSRI) and psychotherapy | 30% | |
Schizophrenia | SCZ1 | Typical antipsychotics | 75% |
SCZ2 | Atypical antipsychotics | 75% | |
SCZ3 | Typical antipsychotics + psychosocial treatment | 75% | |
SCZ4 | Atypical antipsychotics + psychosocial treatment | 75% | |
SCZ5 | Case id + manager: Typical antipsychotics and psychosocial treatment | 75% | |
SCZ6 | Case id + manager: Atypical antipsychotics and psychosocial treatment | 75% | |
Bipolar disorder | BIP1 | Older mood stabilizer (Lithium) | 50% |
BIP2 | Newer mood stabilizer (Valproate) | 50% | |
BIP3 | Older mood stabilizer (Lithium) and psychosocial treatment | 50% | |
BIP4 | Newer mood stabilizer (Valproate) and psychosocial treatment | 50% | |
Epilepsy | EPI1 | Older antiepileptic treatment (Phenobarbital) | 75% |
EPI2 | Newer antiepileptic treatment (Carbomazepine) | 75% |
Disorder . | Intervention number . | Intervention description . | Coverage . |
---|---|---|---|
Depression | DEP1 | Older antidepressants (TCA) | 30% |
DEP2 | Newer antidepressants (SSRI) | 30% | |
DEP3 | Psychotherapy | 30% | |
DEP4 | Older antidepressants (TCA) and psychotherapy | 30% | |
DEP5 | Newer antidepressants (SSRI) and psychotherapy | 30% | |
DEP6 | Maintenance: Older antidepressants (TCA) and psychotherapy | 30% | |
DEP7 | Maintenance: Newer antidepressants (SSRI) and psychotherapy | 30% | |
Schizophrenia | SCZ1 | Typical antipsychotics | 75% |
SCZ2 | Atypical antipsychotics | 75% | |
SCZ3 | Typical antipsychotics + psychosocial treatment | 75% | |
SCZ4 | Atypical antipsychotics + psychosocial treatment | 75% | |
SCZ5 | Case id + manager: Typical antipsychotics and psychosocial treatment | 75% | |
SCZ6 | Case id + manager: Atypical antipsychotics and psychosocial treatment | 75% | |
Bipolar disorder | BIP1 | Older mood stabilizer (Lithium) | 50% |
BIP2 | Newer mood stabilizer (Valproate) | 50% | |
BIP3 | Older mood stabilizer (Lithium) and psychosocial treatment | 50% | |
BIP4 | Newer mood stabilizer (Valproate) and psychosocial treatment | 50% | |
Epilepsy | EPI1 | Older antiepileptic treatment (Phenobarbital) | 75% |
EPI2 | Newer antiepileptic treatment (Carbomazepine) | 75% |
Disorder . | Intervention number . | Intervention description . | Coverage . |
---|---|---|---|
Depression | DEP1 | Older antidepressants (TCA) | 30% |
DEP2 | Newer antidepressants (SSRI) | 30% | |
DEP3 | Psychotherapy | 30% | |
DEP4 | Older antidepressants (TCA) and psychotherapy | 30% | |
DEP5 | Newer antidepressants (SSRI) and psychotherapy | 30% | |
DEP6 | Maintenance: Older antidepressants (TCA) and psychotherapy | 30% | |
DEP7 | Maintenance: Newer antidepressants (SSRI) and psychotherapy | 30% | |
Schizophrenia | SCZ1 | Typical antipsychotics | 75% |
SCZ2 | Atypical antipsychotics | 75% | |
SCZ3 | Typical antipsychotics + psychosocial treatment | 75% | |
SCZ4 | Atypical antipsychotics + psychosocial treatment | 75% | |
SCZ5 | Case id + manager: Typical antipsychotics and psychosocial treatment | 75% | |
SCZ6 | Case id + manager: Atypical antipsychotics and psychosocial treatment | 75% | |
Bipolar disorder | BIP1 | Older mood stabilizer (Lithium) | 50% |
BIP2 | Newer mood stabilizer (Valproate) | 50% | |
BIP3 | Older mood stabilizer (Lithium) and psychosocial treatment | 50% | |
BIP4 | Newer mood stabilizer (Valproate) and psychosocial treatment | 50% | |
Epilepsy | EPI1 | Older antiepileptic treatment (Phenobarbital) | 75% |
EPI2 | Newer antiepileptic treatment (Carbomazepine) | 75% |
Disorder . | Intervention number . | Intervention description . | Coverage . |
---|---|---|---|
Depression | DEP1 | Older antidepressants (TCA) | 30% |
DEP2 | Newer antidepressants (SSRI) | 30% | |
DEP3 | Psychotherapy | 30% | |
DEP4 | Older antidepressants (TCA) and psychotherapy | 30% | |
DEP5 | Newer antidepressants (SSRI) and psychotherapy | 30% | |
DEP6 | Maintenance: Older antidepressants (TCA) and psychotherapy | 30% | |
DEP7 | Maintenance: Newer antidepressants (SSRI) and psychotherapy | 30% | |
Schizophrenia | SCZ1 | Typical antipsychotics | 75% |
SCZ2 | Atypical antipsychotics | 75% | |
SCZ3 | Typical antipsychotics + psychosocial treatment | 75% | |
SCZ4 | Atypical antipsychotics + psychosocial treatment | 75% | |
SCZ5 | Case id + manager: Typical antipsychotics and psychosocial treatment | 75% | |
SCZ6 | Case id + manager: Atypical antipsychotics and psychosocial treatment | 75% | |
Bipolar disorder | BIP1 | Older mood stabilizer (Lithium) | 50% |
BIP2 | Newer mood stabilizer (Valproate) | 50% | |
BIP3 | Older mood stabilizer (Lithium) and psychosocial treatment | 50% | |
BIP4 | Newer mood stabilizer (Valproate) and psychosocial treatment | 50% | |
Epilepsy | EPI1 | Older antiepileptic treatment (Phenobarbital) | 75% |
EPI2 | Newer antiepileptic treatment (Carbomazepine) | 75% |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.